Initial report on intraves1cal administration of N-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladder

Richard E. Greenberg, Peter J. O’Dwyer, Gary D. Steinberg et al.|Urology|1997

Cited by 64